Accurately diagnose autoimmune neurological disorders with the NMO/MOG Antibody test.
The NMO/MOG Antibody test is a specialized blood test used to detect antibodies associated with neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). These are autoimmune disorders that affect the central nervous system, primarily targeting the optic nerves and spinal cord, leading to symptoms such as vision loss, weakness, and sensory disturbances. This test identifies the presence of NMO-IgG antibodies (anti-AQP4 antibodies) and MOG-IgG antibodies, which are key markers for diagnosing these conditions.
The test is recommended for individuals who exhibit symptoms suggestive of NMOSD or MOGAD, such as Unexplained vision loss or optic neuritis. Recurrent episodes of transverse myelitis (spinal cord inflammation). Persistent neurological symptoms, including numbness, weakness, or bladder and bowel dysfunction. A history of relapsing central nervous system disorders that do not meet the criteria for multiple sclerosis. This test is particularly important for patients who require differentiation between NMOSD, MOGAD, and other neurological conditions like multiple sclerosis, as the treatments differ significantly.
This test is critical for the accurate diagnosis of NMOSD and MOGAD, which are often misdiagnosed as multiple sclerosis due to overlapping symptoms. Early and accurate detection allows for the initiation of appropriate therapies that can reduce relapses, prevent permanent damage, and improve the patient’s quality of life. Additionally, identifying the specific antibody (NMO-IgG or MOG-IgG) can guide clinicians in tailoring the treatment plan to the patient’s condition.
The results of the NMO/MOG Antibody test are typically reported as either “positive” or “negative”:
Positive: Indicates the presence of NMO-IgG or MOG-IgG antibodies, confirming a diagnosis of NMOSD or MOGAD.
Negative: Indicates the absence of these antibodies, but further tests may be needed to rule out other conditions.
You should choose Diagnopein for your NMO/MOG Antibody test because we are committed to providing high-quality diagnostic care in a clean and hygienic environment. Our center is equipped with advanced technology to ensure accurate and reliable test results, which are crucial for assessing this test. Diagnopein’s experienced staff is dedicated to handling tests with precision and care, offering you both expertise and comfort. We also offer affordable pricing, making essential health diagnostics accessible without compromising quality. For timely, professional, and affordable cardiac testing, Diagnopein is your trusted partner for your healthcare.
The test involves drawing a blood sample, which is then analyzed in the laboratory for specific antibodies.
Yes, the test detects distinct antibodies—NMO-IgG for NMOSD and MOG-IgG for MOGAD—helping differentiate between the two conditions.
While primarily used for diagnosis, the test may help in understanding the likelihood of relapses in some patients.
No special preparation is required, but it is advisable to inform your doctor about any ongoing medications or medical conditions.